Part 2: VP-315 3 Day Dosing/Week - Loading Dose

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaNCT05188729VRCAPhase 2Completed2024-04-15Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.